BeiGene News

BeiGene | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 15 16:31 ET

BeiGene | 4: Statement of changes in beneficial ownership of securities-Officer OYLER JOHN

Apr 11 18:06 ET

BeiGene | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 9 16:25 ET

BeiGene | 3: Initial statement of beneficial ownership of securities-Officer Ball Titus B.

Mar 26 17:30 ET

BeiGene | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 26 16:23 ET

BeiGene | 8-K: Current report

Mar 20 16:13 ET

BeiGene | 8-K: Current report

Mar 15 16:57 ET

BeiGene | 4: Statement of changes in beneficial ownership of securities-Officer OYLER JOHN

Mar 14 17:25 ET

BeiGene | 4: Statement of changes in beneficial ownership of securities-Director Glazer Donald W.

Mar 13 17:05 ET

BeiGene | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 12 16:36 ET

BeiGene | 8-K: Current report

Mar 8 06:05 ET

BeiGene | 4: Statement of changes in beneficial ownership of securities-Director BRANDICOURT OLIVIER

Mar 4 17:52 ET

BeiGene | 4: Statement of changes in beneficial ownership of securities-Officer Wang Julia Aijun

Mar 4 17:48 ET

BeiGene | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 29 16:34 ET

BeiGene | 10-K: Annual report

Feb 26 06:20 ET

BeiGene | 8-K: Press release titled “BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates”, issued by BeiGene, Ltd. on February 26, 2024

Feb 26 06:06 ET

BeiGene | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital International Investors(7.6%)

Feb 9 18:07 ET

BeiGene | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John V. Oyler(5.2%)

Feb 5 16:14 ET

BeiGene | 3: Initial statement of beneficial ownership of securities-Director BRANDICOURT OLIVIER

Jan 23 00:00 ET

BeiGene | 8-K: Current report

Jan 23 00:00 ET